BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3490287)

  • 1. Low-dose deoxycoformycin in the treatment of hairy cell leukemia.
    Kraut EH; Bouroncle BA; Grever MR
    Blood; 1986 Nov; 68(5):1119-22. PubMed ID: 3490287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of hairy cell leukemia: the Ohio State University experience with deoxycoformycin.
    Bouroncle BA; Grever MR; Kraut EH
    Leukemia; 1987 Apr; 1(4):350-4. PubMed ID: 3499542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2'-Deoxycoformycin (Pentostatin) in hairy cell leukemia: response in patients refractory to interferon alpha.
    Ho AD; Kuse R; Prümmer O; Porzsolt F; Hunstein W
    Klin Wochenschr; 1987 Oct; 65(20):975-9. PubMed ID: 3501501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remissions in hairy-cell leukemia with pentostatin (2'-deoxycoformycin).
    Spiers AS; Moore D; Cassileth PA; Harrington DP; Cummings FJ; Neiman RS; Bennett JM; O'Connell MJ
    N Engl J Med; 1987 Apr; 316(14):825-30. PubMed ID: 2434850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of hairy-cell leukaemia with 2'-deoxycoformycin.
    Johnston JB; Glazer RI; Pugh L; Israels LG
    Br J Haematol; 1986 Jul; 63(3):525-34. PubMed ID: 3488071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hairy-cell leukemia: induction of complete remission with pentostatin (2'-deoxycoformycin).
    Spiers AS; Parekh SJ; Bishop MB
    J Clin Oncol; 1984 Dec; 2(12):1336-42. PubMed ID: 6334721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentostatin in the treatment of advanced hairy cell leukemia.
    Kraut EH; Bouroncle BA; Grever MR
    J Clin Oncol; 1989 Feb; 7(2):168-72. PubMed ID: 2783731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of 2'-deoxycoformycin in hairy-cell leukemia: a study of the National Cancer Institute of Canada Clinical Trials Group.
    Johnston JB; Eisenhauer E; Corbett WE; Scott JG; Zaentz SD
    J Natl Cancer Inst; 1988 Jul; 80(10):765-9. PubMed ID: 3290498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to pentostatin in hairy-cell leukemia refractory to interferon-alpha. The European Organization for Research and Treatment of Cancer Leukemia Cooperative Group.
    Ho AD; Thaler J; Mandelli F; Lauria F; Zittoun R; Willemze R; McVie G; Marmont AM; Prümmer O; Stryckmans P
    J Clin Oncol; 1989 Oct; 7(10):1533-8. PubMed ID: 2789273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistological assessment of bone marrow biopsies from patients with hairy cell leukemia: changes following treatment with alpha-2-interferon and deoxycoformycin.
    Thaler J; Denz H; Dietze O; Gastl G; Ho AD; Gattringer C; Greil R; Lechleitner M; Huber C; Huber H
    Leuk Res; 1989; 13(5):377-83. PubMed ID: 2787447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The treatment of hairy cell leukemia (HCL) with pentostatin (2'-deoxycoformycin, dCF).
    Spiers AS; Parekh SJ
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():173-5. PubMed ID: 2653498
    [No Abstract]   [Full Text] [Related]  

  • 12. Pentostatin (2'deoxycoformycin) for the treatment of lymphoid neoplasms.
    Ho AD; Thaler J; Willemze R; Lauria F; Derossi G; Kuse R; Stryckmans P; Blanc CM; Cataldo F; McVie G
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():60-2. PubMed ID: 2653520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2'-deoxycoformycin (DCF) and 9-beta-D-arabinofuranosyladenine (Ara-A) in the treatment of refractory acute myelocytic leukemia.
    Gray DP; Grever MR; Siaw MF; Coleman MS; Balcerzak SP
    Cancer Treat Rep; 1982 Feb; 66(2):253-7. PubMed ID: 6976833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The treatment of hairy cell leukemia with 2'-deoxycoformycin: results in India and in the United States.
    Spiers AS; Parekh SJ
    Leukemia; 1987 Apr; 1(4):347-50. PubMed ID: 3499541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to 2'-deoxycoformycin after failure of interferon-alpha in nonsplenectomized patients with hairy cell leukemia.
    Foon KA; Nakano GM; Koller CA; Longo DL; Steis RG
    Blood; 1986 Jul; 68(1):297-300. PubMed ID: 3487358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical changes induced in hairy-cell leukemia following treatment with the adenosine deaminase inhibitor 2'-deoxycoformycin.
    Johnston JB; Begleiter A; Pugh L; Leith MK; Wilkins JA; Cavers DJ; Israels LG
    Cancer Res; 1986 Apr; 46(4 Pt 2):2179-84. PubMed ID: 2418965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
    Gotić M; Rolović Z; Radosević N; Draguljac N; Jovanović V; Bogdanović A; Bosković D
    Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hairy cell leukemia with alternating cycles of pentostatin and recombinant leukocyte A interferon: results of a phase II study.
    Martin A; Nerenstone S; Urba WJ; Longo DL; Lawrence JB; Clark JW; Hawkins MJ; Creekmore SP; Smith JW; Steis RG
    J Clin Oncol; 1990 Apr; 8(4):721-30. PubMed ID: 2313337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trials in hairy cell leukemia. Current status and future directions.
    Cheson BD; Martin A
    Ann Intern Med; 1987 Jun; 106(6):871-8. PubMed ID: 3555204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hairy cell leukemia: clinical features and therapeutic advances.
    Lembersky BC; Golomb HM
    Cancer Metastasis Rev; 1987; 6(3):283-300. PubMed ID: 2446791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.